肺T1 mapping磁共振成像评估囊性纤维化儿童肺部疾病:一项初步研究
前瞻性初步研究纳入16例囊性纤维化(CF)患儿,比较肺T1 mapping MRI与超短回波时间(UTE)MRI检测早期肺病及监测急性加重的作用;第一期显示CF患儿归一化T1均值显著低于健康对照且无T1值肺容积百分比显著更高,UTE MRI无显著差异;第二期显示治疗后全肺T1值升高且灌注评分改善,作者认为肺T1 mapping MRI可检测早期区域肺病并可能有助于评估急性加重。
要点
- 肺T1 mapping可显示CF患儿区域性T1值降低及无T1值肺容积百分比升高,UTE MRI未见显著差异。
- 急性加重治疗后全肺T1值升高且灌注评分改善,提示T1 mapping可能用于监测治疗反应。
- 右肺下叶归一化T1值在CF与健康对照间无显著差异(P=0.29),阅片时需注意区域差异。
核心结论
- 肺T1 mapping MRI可检测儿童CF早期区域性肺病,并可能有助于评估急性肺加重。
研究设计与样本
- 前瞻性初步研究,2017年9月至2018年1月纳入16例CF患儿。
- 第一期比较5例肺功能正常的CF患儿(平均11.2岁)与5例年龄性别匹配的健康志愿者。
- 第二期纵向评估6例急性肺加重CF患儿(中位11岁)。
- 所有儿童均行非增强肺T1 mapping和UTE MRI及肺功能检查,并计算CF MRI评分。
关键影像表现/征象
- CF患儿肺归一化T1均值显著低于健康对照(P=0.02),但右肺下叶无显著差异(P=0.29)。
- CF患儿无T1值肺容积百分比显著高于健康对照(P=0.006)。
- UTE MRI在CF患儿与健康志愿者间无显著差异(P=0.11)。
- 第二期排除1例治疗中出现全身性疾病的离群病例后,治疗后全肺T1值升高(P=0.001),灌注评分改善(P=0.02)。
- MRI评分其他项目未见显著变化。
诊断标准与关键数值
- 采用肺T1 mapping测量归一化T1值及无T1值肺容积百分比,并与UTE MRI和肺功能比较。
- CF MRI评分包含灌注评分等项目,治疗后灌注评分改善(P=0.02)。
临床应用与阅片要点
- 肺T1 mapping可作为儿童CF早期区域肺病的补充评估工具,关注归一化T1值降低及无T1值肺容积百分比升高。
- 右肺下叶T1值在CF与健康对照间无显著差异,报告时需结合其他肺叶表现。
- 急性加重治疗后可观察到全肺T1值升高和灌注评分改善,作者认为T1 mapping可能有助于评估急性加重。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Assessment tools for early cystic fibrosis (CF) lung disease are limited. Detecting early pulmonary disease is crucial to increasing life expectancy by starting interventions to slow the progression of the pulmonary disease with the many treatment options available.
OBJECTIVE: To compare the utility of lung T1-mapping MRI with ultrashort echo time (UTE) MRI in children with cystic fibrosis in detecting early stage lung disease and monitoring pulmonary exacerbations.
MATERIALS AND METHODS: We performed a prospective study in 16 children between September 2017 and January 2018. In Phase 1, we compared five CF patients with normal spirometry (mean 11.2 years) to five age- and gender-matched healthy volunteers. In Phase 2, we longitudinally evaluated six CF patients (median 11 years) in acute pulmonary exacerbation. All children had non-contrast lung T1-mapping and UTE MRI and spirometry testing. We compared the mean normalized T1 value and percentage lung volume without T1 value in CF patients and healthy subjects in Phase 1 and during treatment in Phase 2. We also performed cystic fibrosis MRI scoring. We evaluated differences in continuous variables using standard statistical tests.
RESULTS: In Phase 1, mean normalized T1 values of the lung were significantly lower in CF patients in comparison to healthy controls (P=0.02) except in the right lower lobe (P=0.29). The percentage lung volume without T1 value was also significantly higher in CF patients (P=0.006). UTE MRI showed no significant differences between CF patients and healthy volunteers (P=0.11). In Phase 2, excluding one outlier case who developed systemic disease in the course of treatment, the whole-lung T1 value increased (P=0.001) and perfusion scoring improved (P=0.02) following therapy. We observed no other significant changes in the MRI scoring.
CONCLUSION: Lung T1-mapping MRI can detect early regional pulmonary CF disease in children and might be helpful in the assessment of acute pulmonary exacerbations.
引用
- Neemuchwala F, Ghadimi Mahani M, Pang Y, et al. Lung T1 mapping magnetic resonance imaging in the assessment of pulmonary disease in children with cystic fibrosis: a pilot study. Pediatr Radiol. 2020. PMID: 32162080. doi:10.1007/s00247-020-04638-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。